Cancer Res (2024) 84 (6_Supplement): 48. Introduction: Multiple Myeloma (MM) is the second most diagnosed hematologic malignancy and remains an incurable disease. KLN-1010 is a novel treatment for MM ...
Cancer Res (2021) 81 (13_Supplement): 1261.
Abstract. Binding of steroid hormones to their cognate receptors regulates the growth of most prostate and breast cancers. We hypothesized that CYP11A inhibition might halt the synthesis of all ...
Cancer Res (2023) 83 (8_Supplement): LB215.
1Yonsei University, College of Medicine, Seoul, Republic of Korea.
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio ® (avelumab), a ...
1Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, Freiburg University Medical Center, Freiburg, Germany.
Cancer Res (2024) 84 (7_Supplement): LB055.
1Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, New York. 2Department of Physiology and Biophysics, Weill Cornell Medicine, New York, New York.
Suzhou Genhouse Pharmaceutical Co., Ltd., Suzhou, China.
Synnovation Therapeutics, Inc., Wilmington, DE.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback